ANDURIL OPEN TO WEAPONS HUB OUTSIDE US
■ AI-SUMMARIZED FROM 2 SOURCES ▸ TIMELINE
Anduril Industries CEO Brian Schimpf said the defense-tech startup would "absolutely" consider building its next weapons manufacturing hub outside the United States, citing abundant manufacturing talent in Europe.
■ MORE FROM THE STARTUPS DESK
Colorado-based biotech startup Enveda, which uses AI to discover new drugs from natural sources, secured $311 million in Series E funding at a $2 billion valuation—double its valuation from a year ago.
Modal Labs and Baseten, two platforms enabling businesses to run AI models, are in advanced funding talks that would significantly boost their valuations. The rounds reflect growing investor appetite for AI infrastructure services.
Ema, an AI agent platform automating corporate processes in HR, IT, and finance, secured $77 million in Series B funding led by Creaegis. The round brings the startup's total funding to $140 million.
Enveda Therapeutics raised $311 million in funding, bringing the AI biotech company's valuation to $2 billion. The capital will accelerate clinical trials for drugs derived from natural compounds.